Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $8.88 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.62.
Market Cap
8.88T
Revenue
4.59T
Profits
199.05B
PE Ratio
44.62
Profit Margin
4.34%
Dividend Yield
0.39%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -1.12% | 693,010 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 607.12B | -0.65% | 2,989,558 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 434.72B | 0.52% | 1,046,951 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 382.96B | -0.82% | 1,588,872 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 304.36B | 2.03% | 2,802,015 | 65.77B |
| 6 | NVS | Novartis AG | 277.39B | 0.33% | 302,363 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 256.94B | 2.43% | 812,795 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 216.56B | 3.38% | 3,488,546 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 200.21B | 0.88% | 414,680 | 45.20B |
| 10 | AMGN | Amgen Inc. | 192.51B | 0.41% | 321,423 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 163.79B | 1.45% | 1,071,873 | 29.74B |
| 12 | ABT | Abbott Laboratories | 156.03B | 0.70% | 3,481,186 | 45.13B |
| 13 | DHR | Danaher Corporation | 142.18B | 0.92% | 844,184 | 24.78B |
| 14 | PFE | Pfizer Inc. | 140.66B | 1.77% | 9,854,215 | 63.32B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.12B | 2.77% | 1,347,467 | 10.58B |
| 16 | CVS | CVS Health Corporation | 136.27B | 0.58% | 2,194,682 | 405.62B |
| 17 | SYK | Stryker Corporation | 121.48B | 1.86% | 524,748 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 120.91B | 0.02% | 195,523 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 119.64B | 2.88% | 2,713,937 | 48.48B |
| 20 | MDT | Medtronic plc | 104.40B | 2.85% | 2,288,848 | 36.36B |
| 21 | SNY | Sanofi | 103.69B | 0.74% | 538,267 | 54.60B |
| 22 | GSK | GSK plc | 102.50B | 0.67% | 463,248 | 43.29B |
| 23 | MCK | McKesson Corporation | 94.51B | 0.48% | 126,617 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 83.75B | -9.64% | 1,389,411 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.06B | 2.98% | 493,451 | 76.39B |
| 26 | CI | The Cigna Group | 80.39B | 0.18% | 260,504 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.51B | 1.13% | 127,296 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 64.57B | 1.90% | 3,990,410 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.90B | 0.14% | 153,437 | 328.68B |
| 30 | ARGX | argenx SE | 54.49B | 0.30% | 66,372 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 53.57B | -0.60% | 415,883 | 250.74B |
| 32 | MDLN | Medline Inc. | 52.05B | 2.48% | 1,202,129 | 29.14B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 51.59B | 0.06% | 1,515,097 | 28.34B |
| 34 | EW | Edwards Lifesciences Corporation | 50.70B | -2.27% | 2,002,256 | 6.30B |
| 35 | HUM | Humana Inc. | 49.19B | 0.73% | 224,626 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.45B | 4.22% | 232,284 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 43.04B | 3.68% | 383,506 | 22.23B |
| 38 | HLN | Haleon plc | 42.52B | 0.57% | 1,065,799 | 14.85B |
| 39 | NTRA | Natera, Inc. | 39.48B | 1.10% | 193,843 | 2.50B |
| 40 | RVMD | Revolution Medicines, Inc. | 38.98B | -0.87% | 240,273 | - |
| 41 | A | Agilent Technologies, Inc. | 38.41B | 0.59% | 284,626 | 7.23B |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.55B | - | 228,645 | 4.29B |
| 43 | WAT | Waters Corporation | 37.19B | 0.64% | 69,999 | 3.77B |
| 44 | TEVA | Teva Pharmaceutical Industries Limited | 36.98B | -0.19% | 758,704 | 17.35B |
| 45 | IQV | IQVIA Holdings Inc. | 34.97B | 0.81% | 162,068 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 34.77B | 2.02% | 238,598 | 5.74B |
| 47 | CNC | Centene Corporation | 32.96B | -2.88% | 1,267,001 | 178.33B |
| 48 | ALC | Alcon Inc. | 32.72B | 2.54% | 960,912 | 10.63B |
| 49 | RPRX | Royalty Pharma plc | 31.99B | -0.22% | 534,012 | 2.44B |
| 50 | VEEV | Veeva Systems Inc. | 31.84B | 1.51% | 337,889 | 3.32B |
| 51 | ZTS | Zoetis Inc. | 31.68B | 2.03% | 1,038,443 | 9.53B |
| 52 | DXCM | DexCom, Inc. | 28.89B | 1.01% | 463,455 | 4.82B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.81B | 2.72% | 1,313,732 | 20.98B |
| 54 | ILMN | Illumina, Inc. | 28.78B | -0.52% | 228,745 | 4.39B |
| 55 | RMD | ResMed Inc. | 28.63B | 2.85% | 212,664 | 5.54B |
| 56 | BIIB | Biogen Inc. | 28.55B | 0.75% | 535,678 | 9.94B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.79B | 0.83% | 17,862 | 4.09B |
| 58 | MRNA | Moderna, Inc. | 26.59B | -0.62% | 923,611 | 2.23B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.13B | -0.55% | 79,898 | 3.22B |
| 60 | PHG | Koninklijke Philips N.V. | 25.07B | 3.84% | 404,217 | 20.34B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.05B | -0.23% | 481,393 | 8.26M |
| 62 | INSM | Insmed Incorporated | 23.63B | -0.98% | 562,193 | 819.56M |
| 63 | BNTX | BioNTech SE | 22.83B | -0.12% | 121,203 | 3.23B |
| 64 | INCY | Incyte Corporation | 22.79B | -0.72% | 360,465 | 5.36B |
| 65 | DGX | Quest Diagnostics Incorporated | 22.68B | -0.53% | 192,981 | 11.28B |
| 66 | UTHR | United Therapeutics Corporation | 22.59B | 1.05% | 55,989 | 3.17B |
| 67 | LH | Labcorp Holdings Inc. | 22.53B | -0.35% | 81,673 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 21.66B | 2.01% | 320,042 | 1.08B |
| 69 | STE | STERIS plc | 20.82B | 2.34% | 99,901 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.16B | 0.86% | 1,204,417 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.78B | 0.97% | 582,492 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.48B | 1.46% | 902,931 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.22B | -0.44% | 118,594 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 16.43B | 3.84% | 351,952 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.42B | -0.46% | 93,825 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.21B | -1.66% | 614,946 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.23B | -0.52% | 56,434 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.06B | 0.73% | 70,166 | 4.44B |
| 79 | DVA | DaVita Inc. | 14.68B | -1.58% | 94,059 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.10B | -2.86% | 1,118,707 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 13.95B | -0.50% | 275,948 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.91B | 4.10% | 507,333 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.64B | 3.25% | 175,577 | 8.26B |
| 84 | ALGN | Align Technology, Inc. | 13.08B | 2.37% | 100,742 | 4.10B |
| 85 | FMS | Fresenius Medical Care AG | 12.90B | -0.91% | 228,773 | 22.32B |
| 86 | ICLR | ICON Public Limited Company | 12.88B | 0.07% | 109,730 | 8.27B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.78B | 0.12% | 762,511 | 4.89B |
| 88 | SNN | Smith & Nephew plc | 12.57B | 3.79% | 1,421,153 | 6.16B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.51B | 1.05% | 50,670 | 1.13B |
| 90 | RVTY | Revvity, Inc. | 12.48B | 0.57% | 126,732 | 2.90B |
| 91 | PEN | Penumbra, Inc. | 12.48B | 0.30% | 43,944 | 1.45B |
| 92 | MOH | Molina Healthcare, Inc. | 12.04B | -4.32% | 444,050 | 43.10B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 11.95B | -1.33% | 78,551 | 708.24M |
| 94 | SMMT | Summit Therapeutics Inc. | 11.80B | -1.75% | 479,897 | - |
| 95 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 11.71B | 0.59% | 332,405 | 5.67M |
| 96 | BAX | Baxter International Inc. | 11.53B | 2.43% | 861,141 | 11.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.38B | 0.44% | 132,210 | 3.24B |
| 98 | PODD | Insulet Corporation | 11.25B | 2.03% | 185,332 | 2.90B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.18B | 0.51% | 306,600 | 105.82M |
| 100 | TECH | Bio-Techne Corporation | 11.14B | 0.36% | 521,227 | 1.21B |
| 101 | CRL | Charles River Laboratories International, Inc. | 11.03B | -0.98% | 179,164 | 4.03B |
| 102 | EHC | Encompass Health Corporation | 10.87B | 0.79% | 118,640 | 6.07B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.66B | 0.43% | 282,641 | 3.58B |
| 104 | GMED | Globus Medical, Inc. | 10.56B | 2.56% | 227,773 | 3.10B |
| 105 | TEM | Tempus AI, Inc. | 10.47B | -0.63% | 839,173 | 1.36B |
| 106 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.06B | -0.71% | 417,415 | 622.01M |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.05B | 0.10% | 199,861 | - |
| 108 | HSIC | Henry Schein, Inc. | 9.99B | 0.90% | 220,484 | 13.38B |
| 109 | KRYS | Krystal Biotech, Inc. | 9.98B | -0.24% | 100,258 | 417.30M |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | - | - | - |
| 111 | ENSG | The Ensign Group, Inc. | 9.78B | 1.22% | 82,755 | 5.27B |
| 112 | OSCR | Oscar Health, Inc. | 9.50B | 1.54% | 1,239,651 | 13.30B |
| 113 | CORT | Corcept Therapeutics Incorporated | 9.38B | -3.42% | 195,586 | 769.10M |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.33B | 1.18% | 90,479 | 51.48M |
| 115 | GKOS | Glaukos Corporation | 9.16B | 2.37% | 98,507 | 551.35M |
| 116 | BRKR | Bruker Corporation | 9.13B | 0.20% | 616,509 | 3.46B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 8.94B | -1.49% | 595,925 | 1.06B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 8.93B | 0.28% | 174,213 | 1.51B |
| 119 | UHS | Universal Health Services, Inc. | 8.91B | 2.03% | 151,346 | 17.76B |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 8.87B | -2.89% | 44,584 | 7.46M |
| 121 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.31% | 796,080 | 18.07M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.77B | 3.92% | 154,258 | 74.06M |
| 123 | QGEN | Qiagen N.V. | 8.66B | 0.77% | 672,256 | 2.10B |
| 124 | SYRE | Spyre Therapeutics, Inc. | 8.63B | -0.83% | 196,203 | - |
| 125 | ALKS | Alkermes plc | 8.58B | -0.21% | 249,704 | 1.56B |
| 126 | HIMS | Hims & Hers Health, Inc. | 8.55B | 5.04% | 5,070,875 | 2.37B |
| 127 | RGEN | Repligen Corporation | 8.36B | 0.72% | 193,906 | 763.34M |
| 128 | ATR | AptarGroup, Inc. | 8.31B | 1.48% | 97,632 | 3.87B |
| 129 | PCVX | Vaxcyte, Inc. | 8.07B | -0.52% | 172,339 | - |
| 130 | IBRX | ImmunityBio, Inc. | 8.05B | -2.47% | 2,063,111 | 140.98M |
| 131 | IMVT | Immunovant, Inc. | 8.04B | 0.98% | 151,090 | - |
| 132 | BIO | Bio-Rad Laboratories, Inc. | 8.00B | 0.25% | 32,933 | 2.59B |
| 133 | HQY | HealthEquity, Inc. | 7.95B | 0.59% | 207,713 | 1.34B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.80B | 0.28% | 401,305 | 700.35M |
| 135 | AVTR | Avantor, Inc. | 7.69B | -0.22% | 2,173,714 | 6.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.47B | -0.92% | 98,998 | 217.17M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 7.25B | -1.72% | 38,183 | 569.61M |
| 138 | PACS | PACS Group, Inc. | 7.11B | -0.11% | 288,801 | 5.43B |
| 139 | HNGE | Hinge Health, Inc. | 6.83B | -1.10% | 129,427 | 646.34M |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.82B | 2.31% | 97,744 | 1.55B |
| 141 | COGT | Cogent Biosciences, Inc. | 6.72B | 2.05% | 488,218 | - |
| 142 | LQDA | Liquidia Corporation | 6.68B | -1.84% | 201,937 | 288.07M |
| 143 | CGON | CG Oncology, Inc. | 6.58B | 3.90% | 156,117 | 5.07M |
| 144 | CHE | Chemed Corporation | 6.53B | 0.39% | 22,471 | 2.54B |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.52B | 0.68% | 177,413 | 827.11M |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 6.49B | -0.18% | 166,588 | 7.50M |
| 147 | ERAS | Erasca, Inc. | 6.47B | 6.77% | 2,511,655 | - |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.47B | 0.39% | 86,563 | - |
| 149 | DFTX | Definium Therapeutics, Inc. | 6.11B | 0.09% | 368,377 | - |
| 150 | GRFS | Grifols, S.A. | 6.10B | 2.21% | 117,857 | 8.58B |
| 151 | BLLN | BillionToOne, Inc. | 5.93B | 3.31% | 232,653 | 354.54M |
| 152 | TFX | Teleflex Incorporated | 5.92B | 2.79% | 123,318 | 2.13B |
| 153 | BLCO | Bausch + Lomb Corporation | 5.85B | 2.79% | 161,479 | 5.21B |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.84B | -1.98% | 74,248 | 274.48M |
| 155 | TWST | Twist Bioscience Corporation | 5.80B | 0.75% | 275,906 | 409.48M |
| 156 | BLTE | Belite Bio, Inc | 5.75B | -0.32% | 27,818 | - |
| 157 | TXG | 10x Genomics, Inc. | 5.73B | -1.42% | 676,040 | 638.78M |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.47B | 2.82% | 383,158 | 3.05B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.46B | -1.31% | 158,380 | 1.34M |
| 160 | STVN | Stevanato Group S.p.A. | 5.43B | 0.35% | 40,779 | 1.39B |
| 161 | MANE | Veradermics, Incorporated | 5.28B | 14.62% | 510,071 | - |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.24B | -1.21% | 139,727 | 536.20M |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.18B | -1.73% | 164,410 | - |
| 164 | SHC | Sotera Health Company | 5.18B | 2.25% | 237,593 | 1.19B |
| 165 | CAI | Caris Life Sciences, Inc. | 4.99B | 4.07% | 2,354,567 | 907.29M |
| 166 | CRSP | CRISPR Therapeutics AG | 4.97B | 0.10% | 458,156 | 4.10M |
| 167 | INDV | Indivior Pharmaceuticals, Inc. | 4.95B | 0.99% | 155,973 | 1.29B |
| 168 | RDNT | RadNet, Inc. | 4.93B | -0.14% | 225,499 | 2.14B |
| 169 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.73B | -0.79% | 89,511 | 754.05M |
| 170 | VCYT | Veracyte, Inc. | 4.66B | 3.06% | 255,704 | 541.74M |
| 171 | LEGN | Legend Biotech Corporation | 4.58B | -7.75% | 2,387,104 | 1.14B |
| 172 | ACAD | ACADIA Pharmaceuticals Inc. | 4.43B | 1.57% | 210,982 | 1.10B |
| 173 | MMED | MiniMed Group, Inc. | 4.43B | 4.92% | 155,687 | 3.10B |
| 174 | LIVN | LivaNova PLC | 4.43B | 1.92% | 156,091 | 1.43B |
| 175 | CELC | Celcuity Inc. | 4.43B | -18.25% | 3,926,793 | - |
| 176 | WAY | Waystar Holding Corp. | 4.42B | 3.83% | 540,269 | 1.16B |
| 177 | VKTX | Viking Therapeutics, Inc. | 4.41B | 0.08% | 349,990 | - |
| 178 | NVST | Envista Holdings Corporation | 4.36B | 2.60% | 422,840 | 2.81B |
| 179 | MMSI | Merit Medical Systems, Inc. | 4.35B | 2.66% | 104,502 | 1.54B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.33B | 1.05% | 594,239 | 56.99M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 4.29B | 0.40% | 216,433 | - |
| 182 | ALHC | Alignment Healthcare, Inc. | 4.29B | -2.17% | 428,637 | 4.26B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.23B | 0.97% | 494,099 | 1.49B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.05% | 252,721 | 10.68M |
| 185 | DOCS | Doximity, Inc. | 4.11B | 3.07% | 362,379 | 644.86M |
| 186 | ICUI | ICU Medical, Inc. | 4.02B | 4.78% | 105,642 | 2.16B |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 3.97B | 0.31% | 109,285 | 2.23B |
| 188 | DYN | Dyne Therapeutics, Inc. | 3.96B | 0.67% | 218,339 | - |
| 189 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | - | 596.96M |
| 190 | PBLS | Parabilis Medicines, Inc. | 3.81B | -4.01% | 102,848 | - |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.81B | 1.84% | 11,751 | 803.79M |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.78B | 2.23% | 99,575 | 787.85M |
| 193 | NAMS | NewAmsterdam Pharma Company N.V. | 3.74B | -3.97% | 194,435 | 22.57M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.63B | 0.93% | 605,352 | - |
| 195 | ELVN | Enliven Therapeutics, Inc. | 3.62B | 0.19% | 74,777 | - |
| 196 | WRBY | Warby Parker Inc. | 3.61B | 6.45% | 452,303 | 890.57M |
| 197 | ADPT | Adaptive Biotechnologies Corporation | 3.60B | 5.04% | 715,510 | 295.41M |
| 198 | OGN | Organon & Co. | 3.55B | - | 282,528 | 6.16B |
| 199 | RCUS | Arcus Biosciences, Inc. | 3.51B | -1.59% | 93,069 | 236.00M |
| 200 | PRVA | Privia Health Group, Inc. | 3.49B | -1.14% | 220,202 | 2.25B |
| 201 | GPCR | Structure Therapeutics Inc. | 3.49B | -2.94% | 168,502 | - |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 0.14% | 90,529 | 225.27M |
| 203 | HAE | Haemonetics Corporation | 3.47B | 2.74% | 144,482 | 1.33B |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.45B | 3.02% | 330,053 | 415.62M |
| 205 | BKD | Brookdale Senior Living Inc. | 3.45B | 1.80% | 570,704 | 3.00B |
| 206 | OPCH | Option Care Health, Inc. | 3.45B | 2.76% | 467,604 | 5.67B |
| 207 | ALMS | Alumis Inc. | 3.42B | -1.69% | 192,833 | 8.40M |
| 208 | NHC | National HealthCare Corporation | 3.35B | 1.89% | 17,243 | 1.53B |
| 209 | ITGR | Integer Holdings Corporation | 3.24B | 2.15% | 98,642 | 1.86B |
| 210 | GRAL | GRAIL, Inc. | 3.15B | 0.36% | 67,163 | 156.12M |
| 211 | RARE | Ultragenyx Pharmaceutical Inc. | 3.09B | -1.87% | 219,107 | 670.00M |
| 212 | BEAM | Beam Therapeutics Inc. | 3.05B | -0.91% | 314,706 | 164.01M |
| 213 | VERA | Vera Therapeutics, Inc. | 3.03B | -2.02% | 262,044 | - |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 3.01B | 3.70% | 662,717 | 3.37B |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.98B | -0.42% | 65,006 | 865.00K |
| 216 | IRON | Disc Medicine, Inc. | 2.86B | -0.04% | 60,814 | - |
| 217 | QURE | uniQure N.V. | 2.80B | -1.85% | 288,531 | 18.09M |
| 218 | MBX | MBX Biosciences, Inc. | 2.76B | 2.58% | 421,176 | - |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | 0.26% | 110,768 | 776.83M |
| 220 | RGC | Regencell Bioscience Holdings Limited | 2.66B | -4.96% | 131,817 | - |
| 221 | XRAY | DENTSPLY SIRONA Inc. | 2.65B | 4.17% | 1,354,332 | 3.68B |
| 222 | ESTA | Establishment Labs Holdings Inc. | 2.65B | 3.93% | 62,311 | 229.58M |
| 223 | TMDX | TransMedics Group, Inc. | 2.63B | 1.90% | 131,846 | 635.89M |
| 224 | SLS | SELLAS Life Sciences Group, Inc. | 2.61B | -0.82% | 1,910,402 | - |
| 225 | KOD | Kodiak Sciences Inc. | 2.57B | -4.74% | 173,417 | - |
| 226 | IMNM | Immunome, Inc. | 2.56B | 0.22% | 93,194 | 4.02M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.52B | 0.20% | 36,380 | 1.46B |
| 228 | PGNY | Progyny, Inc. | 2.51B | -0.93% | 186,564 | 1.29B |
| 229 | CLOV | Clover Health Investments, Corp. | 2.47B | -2.70% | 1,260,445 | 2.21B |
| 230 | KLRA | Kailera Therapeutics, Inc. | 2.47B | 0.16% | 33,048 | - |
| 231 | TRVI | Trevi Therapeutics, Inc. | 2.46B | -3.35% | 252,353 | - |
| 232 | PHVS | Pharvaris N.V. | 2.43B | 1.01% | 54,966 | - |
| 233 | NRIX | Nurix Therapeutics, Inc. | 2.42B | 1.65% | 149,835 | 36.77M |
| 234 | VCEL | Vericel Corporation | 2.40B | 1.82% | 112,397 | 292.09M |
| 235 | HTFL | HeartFlow, Inc. | 2.38B | 8.28% | 295,600 | 191.42M |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -1.36% | 120,395 | - |
| 237 | AGIO | Agios Pharmaceuticals, Inc. | 2.36B | -0.70% | 113,069 | 66.05M |
| 238 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.35B | -4.93% | 2,892,329 | 885.72M |
| 239 | TARS | Tarsus Pharmaceuticals, Inc. | 2.35B | -2.62% | 286,990 | 535.08M |
| 240 | MESO | Mesoblast Limited | 2.35B | 7.47% | 267,330 | 65.38M |
| 241 | ASTH | Astrana Health, Inc. | 2.32B | -4.31% | 158,112 | 3.53B |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.30B | 2.73% | 66,534 | 1.09B |
| 243 | ZLAB | Zai Lab Limited | 2.28B | 5.16% | 380,420 | 453.28M |
| 244 | LMAT | LeMaitre Vascular, Inc. | 2.27B | 1.61% | 56,529 | 256.28M |
| 245 | NKTR | Nektar Therapeutics | 2.26B | -0.33% | 166,853 | 55.63M |
| 246 | BHVN | Biohaven Ltd. | 2.23B | -0.94% | 181,175 | - |
| 247 | NEOG | Neogen Corporation | 2.20B | 4.65% | 217,646 | 870.56M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 1.34% | 38,111 | - |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.14B | 0.93% | 267,522 | 52.04M |
| 250 | OMCL | Omnicell, Inc. | 2.14B | 2.20% | 143,081 | 1.23B |
| 251 | VRDN | Viridian Therapeutics, Inc. | 2.12B | 0.63% | 341,302 | 70.92M |
| 252 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | -1.37% | 454,682 | 217.17M |
| 253 | NBTX | Nanobiotix S.A. | 2.10B | -4.15% | 34,815 | 38.27M |
| 254 | MD | Pediatrix Medical Group, Inc. | 2.09B | 7.88% | 350,445 | 1.93B |
| 255 | ABCL | AbCellera Biologics Inc. | 2.07B | 0.74% | 952,655 | 79.21M |
| 256 | AVAH | Aveanna Healthcare Holdings Inc. | 2.06B | 1.39% | 523,415 | 2.52B |
| 257 | AXGN | Axogen, Inc. | 2.06B | -0.05% | 170,603 | 238.11M |
| 258 | ATAI | AtaiBeckley Inc. | 2.05B | -1.59% | 2,203,282 | 3.49M |
| 259 | NUVB | Nuvation Bio Inc. | 2.04B | -0.68% | 2,069,008 | 143.05M |
| 260 | ADMA | ADMA Biologics, Inc. | 2.03B | -1.13% | 476,701 | 509.86M |
| 261 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | -1.63% | 213,491 | 298.30M |
| 262 | ADUS | Addus HomeCare Corporation | 2.02B | 1.77% | 37,631 | 1.45B |
| 263 | SGRY | Surgery Partners, Inc. | 2.00B | 1.92% | 280,653 | 3.34B |
| 264 | HCM | HUTCHMED (China) Limited | 1.99B | 2.49% | 20,639 | 548.51M |
| 265 | HRMY | Harmony Biosciences Holdings, Inc. | 1.99B | -1.21% | 108,769 | 899.11M |
| 266 | KARD | Kardigan, Inc. | 1.98B | -0.36% | 75,482 | - |
| 267 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | -0.30% | 169,023 | 42.95M |
| 268 | AGL | agilon health, inc. | 1.97B | -3.55% | 73,022 | 5.82B |
| 269 | BFLY | Butterfly Network, Inc. | 1.96B | -3.48% | 2,815,869 | 102.92M |
| 270 | COAG | Hemab Therapeutics Holdings, Inc. | 1.96B | -3.32% | 94,482 | - |
| 271 | LKFT | Lakefront Biotherapeutics NV | 1.94B | 0.14% | 19,052 | 1.20B |
| 272 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.93B | -4.51% | 211,622 | -665.00K |
| 273 | RAPP | Rapport Therapeutics, Inc. | 1.93B | -2.70% | 51,083 | 20.00M |
| 274 | SION | Sionna Therapeutics, Inc. | 1.93B | 0.26% | 187,958 | - |
| 275 | URGN | UroGen Pharma Ltd. | 1.91B | 0.15% | 86,947 | 140.49M |
| 276 | TYRA | Tyra Biosciences, Inc. | 1.90B | -2.98% | 83,401 | - |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 1.89B | 3.51% | 429,054 | 7.47M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.88B | 0.74% | 45,612 | 367.34M |
| 279 | NEO | NeoGenomics, Inc. | 1.87B | 1.12% | 642,315 | 745.97M |
| 280 | ALMR | Alamar Biosciences, Inc. | 1.87B | -0.22% | 45,423 | 87.16M |
| 281 | WGS | GeneDx Holdings Corp. | 1.86B | 0.40% | 107,187 | 442.68M |
| 282 | DMRA | Damora Therapeutics, Inc. | 1.86B | -2.48% | 150,384 | - |
| 283 | NTLA | Intellia Therapeutics, Inc. | 1.85B | -0.38% | 692,607 | 66.09M |
| 284 | UFPT | UFP Technologies, Inc. | 1.85B | 3.90% | 96,733 | 608.85M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.83B | -0.68% | 49,779 | - |
| 286 | NVCR | NovoCure Limited | 1.83B | 1.80% | 131,057 | 674.41M |
| 287 | STOK | Stoke Therapeutics, Inc. | 1.83B | 0.86% | 114,509 | 32.08M |
| 288 | AAPG | Ascentage Pharma Group International | 1.83B | 3.82% | 7,042 | 82.08M |
| 289 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -3.95% | 961,298 | 2.18B |
| 290 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 2.69% | 5,034,276 | 66.41M |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.82B | 3.56% | 12,845,158 | 285.61M |
| 292 | GHRS | GH Research PLC | 1.82B | -1.10% | 6,933 | - |
| 293 | BHC | Bausch Health Companies Inc. | 1.82B | 2.32% | 359,530 | 10.53B |
| 294 | PGEN | Precigen, Inc. | 1.81B | -1.07% | 496,916 | 31.60M |
| 295 | PLSE | Pulse Biosciences, Inc. | 1.78B | 0.94% | 43,445 | 751.00K |
| 296 | ZYME | Zymeworks Inc. | 1.78B | 0.73% | 50,048 | 81.26M |
| 297 | ATRC | AtriCure, Inc. | 1.78B | 2.16% | 80,040 | 552.16M |
| 298 | GENB | Generate Biomedicines, Inc. | 1.77B | -2.60% | 110,023 | 30.30M |
| 299 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -3.09% | 129,916 | 10.00M |
| 300 | CMPS | COMPASS Pathways plc | 1.75B | -3.36% | 803,465 | - |
| 301 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.73B | 3.07% | 584,371 | 204.73M |
| 302 | TDOC | Teladoc Health, Inc. | 1.73B | 3.13% | 864,810 | 2.51B |
| 303 | ABSI | Absci Corporation | 1.71B | -1.08% | 1,114,446 | 1.84M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | 0.29% | 40,928 | 923.71M |
| 305 | IMCR | Immunocore Holdings plc | 1.71B | 0.39% | 69,984 | 412.81M |
| 306 | TRLV | Trulieve Cannabis Corp. | 1.70B | -2.43% | 225,053 | 1.17B |
| 307 | FTRE | Fortrea Holdings Inc. | 1.68B | -1.66% | 188,131 | 2.71B |
| 308 | ANAB | AnaptysBio, Inc. | 1.68B | -9.42% | 513,012 | 232.39M |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.67B | 1.54% | 124,700 | 1.85B |
| 310 | MPLT | MapLight Therapeutics, Inc. | 1.62B | -5.57% | 107,684 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.62B | -1.97% | 100,939 | 20.00M |
| 312 | PSNL | Personalis, Inc. | 1.62B | 2.73% | 1,249,486 | 64.52M |
| 313 | INVA | Innoviva, Inc. | 1.61B | 0.51% | 158,718 | 420.69M |
| 314 | MLTX | MoonLake Immunotherapeutics | 1.61B | -0.05% | 265,569 | - |
| 315 | VIR | Vir Biotechnology, Inc. | 1.61B | 0.58% | 263,909 | 65.50M |
| 316 | INNV | InnovAge Holding Corp. | 1.60B | 1.38% | 46,116 | 949.17M |
| 317 | HROW | Harrow, Inc. | 1.55B | 0.56% | 141,312 | 268.68M |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.54B | 1.35% | 52,270 | - |
| 319 | SEPN | Septerna, Inc. | 1.53B | -1.88% | 58,025 | 72.26M |
| 320 | CDNA | CareDx, Inc. | 1.51B | 1.24% | 107,049 | 412.82M |
| 321 | ENOV | Enovis Corporation | 1.48B | 4.58% | 205,021 | 2.28B |
| 322 | IART | Integra LifeSciences Holdings Corporation | 1.47B | 2.83% | 106,736 | 1.64B |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.46B | 3.40% | 143,994 | 915.25M |
| 324 | SVRA | Savara Inc. | 1.45B | 0.53% | 235,947 | - |
| 325 | XERS | Xeris Biopharma Holdings, Inc. | 1.45B | 1.33% | 284,685 | 314.85M |
| 326 | PRGO | Perrigo Company plc | 1.43B | 4.24% | 642,298 | 4.18B |
| 327 | BLFS | BioLife Solutions, Inc. | 1.42B | 1.78% | 101,343 | 101.66M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.41B | 2.23% | 277,576 | 787.08M |
| 329 | PNTG | The Pennant Group, Inc. | 1.40B | 1.46% | 32,593 | 1.02B |
| 330 | OMDA | Omada Health, Inc. | 1.40B | 0.51% | 606,475 | 283.30M |
| 331 | ARDT | Ardent Health, Inc. | 1.40B | -0.51% | 158,052 | 6.43B |
| 332 | AHCO | AdaptHealth Corp. | 1.39B | 2.65% | 179,465 | 3.29B |
| 333 | STAA | STAAR Surgical Company | 1.39B | 2.27% | 74,345 | 290.38M |
| 334 | NVAX | Novavax, Inc. | 1.39B | 0.36% | 736,558 | 596.34M |
| 335 | KMTS | Kestra Medical Technologies, Ltd. | 1.38B | -2.56% | 309,119 | 95.13M |
| 336 | PAHC | Phibro Animal Health Corporation | 1.38B | 2.60% | 32,282 | 1.50B |
| 337 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -0.40% | 32,921 | 1.30M |
| 338 | AKTS | Aktis Oncology, Inc. | 1.35B | -3.00% | 47,544 | 8.28M |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.30B | 3.28% | 105,849 | 3.42B |
| 340 | CNMD | CONMED Corporation | 1.30B | 3.23% | 135,344 | 1.37B |
| 341 | IMTX | Immatics N.V. | 1.30B | 1.39% | 119,479 | 43.00M |
| 342 | ARDX | Ardelyx, Inc. | 1.28B | 0.78% | 662,815 | 427.68M |
| 343 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 0.13% | 223,055 | - |
| 344 | JBIO | Jade Biosciences, Inc. | 1.26B | -0.73% | 191,717 | - |
| 345 | AVLN | Avalyn Pharma Inc. | 1.25B | -0.27% | 29,501 | - |
| 346 | TRAX | First Tracks Biotherapeutics, Inc. | 1.25B | 4.00% | 80,149 | - |
| 347 | QDEL | QuidelOrtho Corporation | 1.24B | 3.28% | 259,877 | 2.66B |
| 348 | SDGR | Schrรถdinger, Inc. | 1.23B | 1.98% | 242,750 | 254.91M |
| 349 | AZTA | Azenta, Inc. | 1.22B | 4.01% | 103,748 | 596.48M |
| 350 | NUTX | Nutex Health Inc. | 1.22B | -0.73% | 20,283 | 879.95M |
| 351 | MNKD | MannKind Corporation | 1.21B | 1.16% | 1,091,655 | 360.78M |
| 352 | IRMD | IRADIMED CORPORATION | 1.20B | 2.64% | 40,833 | 86.28M |
| 353 | AHG | Akso Health Group | 1.19B | -8.55% | 520 | 14.84M |
| 354 | ALVO | Alvotech | 1.19B | 1.06% | 53,156 | 562.04M |
| 355 | CAPR | Capricor Therapeutics, Inc. | 1.18B | -1.45% | 209,664 | 11.13M |
| 356 | MGTX | MeiraGTx Holdings plc | 1.18B | 2.01% | 130,002 | 79.76M |
| 357 | AORT | Artivion, Inc. | 1.17B | 4.24% | 58,610 | 458.69M |
| 358 | AVNS | Avanos Medical, Inc. | 1.17B | 0.16% | 75,468 | 715.90M |
| 359 | WVE | Wave Life Sciences Ltd. | 1.16B | -1.39% | 332,703 | 71.80M |
| 360 | EYPT | EyePoint, Inc. | 1.15B | 0.15% | 159,362 | 7.61M |
| 361 | ORIC | ORIC Pharmaceuticals, Inc. | 1.14B | 4.74% | 296,451 | - |
| 362 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | 0.54% | 35,332 | 796.33M |
| 363 | DRTS | Alpha Tau Medical Ltd. | 1.14B | 2.59% | 186,388 | - |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.10B | 0.78% | 16,127 | - |
| 365 | GMRS | GMR Solutions Inc. | 1.10B | 0.64% | 42,736 | 5.83B |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | -0.36% | 810,144 | 322.02M |
| 367 | XNCR | Xencor, Inc. | 1.09B | -1.27% | 60,339 | 97.36M |
| 368 | FBRX | Forte Biosciences, Inc. | 1.09B | 3.18% | 129,095 | - |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | -0.79% | 144,169 | - |
| 370 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | 1.67% | 247,138 | 1.03B |
| 371 | CERT | Certara, Inc. | 1.08B | 4.12% | 520,270 | 419.75M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 1.07B | 0.84% | 43,775 | 787.69M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | 1.83% | 317,241 | 1.03B |
| 374 | SANA | Sana Biotechnology, Inc. | 1.06B | -1.40% | 454,240 | - |
| 375 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 1.27% | 102,083 | - |
| 376 | CRON | Cronos Group Inc. | 1.03B | 1.45% | 235,106 | 159.54M |
| 377 | IVA | Inventiva S.A. | 1.03B | 2.50% | 339,999 | 7.94M |
| 378 | GDRX | GoodRx Holdings, Inc. | 1.03B | 1.00% | 205,561 | 787.89M |
| 379 | ETON | Eton Pharmaceuticals, Inc. | 1.03B | -0.16% | 34,226 | 86.93M |
| 380 | BIOA | BioAge Labs, Inc. | 1.01B | -0.04% | 101,913 | 10.32M |
| 381 | KURA | Kura Oncology, Inc. | 1.00B | 0.36% | 215,230 | 71.64M |
| 382 | VOR | Vor Biopharma Inc. | 1.00B | -0.22% | 223,904 | - |
| 383 | BVS | Bioventus Inc. | 999.08M | 3.46% | 125,429 | 576.30M |
| 384 | PCRX | Pacira BioSciences, Inc. | 993.54M | 0.96% | 56,322 | 734.86M |
| 385 | JANX | Janux Therapeutics, Inc. | 972.70M | 1.08% | 265,391 | 13.73M |
| 386 | AVTX | Avalo Therapeutics, Inc. | 969.31M | 0.11% | 122,950 | 59.00K |
| 387 | DBVT | DBV Technologies S.A. | 959.63M | -2.26% | 62,133 | 5.74M |
| 388 | GLAS | Glass House Brands Inc. | 950.29M | -2.19% | 51,748 | 177.68M |
| 389 | ANRO | Alto Neuroscience, Inc. | 943.85M | -3.26% | 84,000 | - |
| 390 | PHAR | Pharming Group N.V. | 942.72M | -0.11% | 1,575 | 369.49M |
| 391 | SLDB | Solid Biosciences Inc. | 928.38M | -2.08% | 158,364 | - |
| 392 | OPK | OPKO Health, Inc. | 924.99M | 0.41% | 652,219 | 581.12M |
| 393 | ANNX | Annexon, Inc. | 924.89M | 1.71% | 748,034 | - |
| 394 | LXRX | Lexicon Pharmaceuticals, Inc. | 919.49M | -2.36% | 546,753 | 69.64M |
| 395 | LBRX | LB Pharmaceuticals Inc | 910.34M | -0.86% | 19,293 | - |
| 396 | GERN | Geron Corporation | 898.13M | 1.45% | 1,686,669 | 196.12M |
| 397 | ABUS | Arbutus Biopharma Corporation | 894.85M | -1.74% | 262,567 | 191.45M |
| 398 | TBPH | Theravance Biopharma, Inc. | 880.04M | 0.35% | 37,472 | 109.78M |
| 399 | FTH | Faeth Therapeutics, Inc. | 875.45M | 2.54% | 164,852 | - |
| 400 | TALK | Talkspace, Inc. | 874.42M | - | 439,530 | 238.37M |
| 401 | INMD | InMode Ltd. | 871.70M | 1.64% | 101,547 | 374.64M |
| 402 | AVR | Anteris Technologies Global Corp. | 859.16M | -1.45% | 135,941 | 1.85M |
| 403 | PHAT | Phathom Pharmaceuticals, Inc. | 853.87M | -2.58% | 370,735 | 204.89M |
| 404 | DSGN | Design Therapeutics, Inc. | 848.79M | -0.59% | 28,688 | - |
| 405 | AMPH | Amphastar Pharmaceuticals, Inc. | 845.26M | 1.94% | 47,316 | 720.53M |
| 406 | HSTM | HealthStream, Inc. | 842.42M | 1.46% | 20,159 | 311.78M |
| 407 | REPL | Replimune Group, Inc. | 813.43M | -1.82% | 536,941 | - |
| 408 | ODTX | Odyssey Therapeutics, Inc. | 800.04M | -3.47% | 42,280 | 1.06M |
| 409 | TENX | Tenax Therapeutics, Inc. | 797.03M | 0.26% | 154,053 | - |
| 410 | NGNE | Neurogene Inc. | 789.90M | 1.43% | 48,511 | 925.00K |
| 411 | CLYM | Climb Bio, Inc. | 777.60M | 2.57% | 132,931 | - |
| 412 | CTMX | CytomX Therapeutics, Inc. | 777.20M | -2.46% | 464,052 | 35.54M |
| 413 | AURA | Aura Biosciences, Inc. | 770.99M | -0.14% | 62,884 | - |
| 414 | OCS | Oculis Holding AG | 770.55M | -1.31% | 37,241 | 1.40M |
| 415 | BBNX | Beta Bionics, Inc. | 769.58M | 2.43% | 132,457 | 110.24M |
| 416 | SIBN | SI-BONE, Inc. | 765.03M | 2.01% | 97,199 | 206.22M |
| 417 | EVO | Evotec SE | 762.74M | -6.54% | 97,165 | 859.03M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 761.17M | 0.37% | 185,780 | 8.37M |
| 419 | RIGL | Rigel Pharmaceuticals, Inc. | 758.59M | -0.41% | 54,399 | 299.77M |
| 420 | ZVRA | Zevra Therapeutics, Inc. | 756.08M | -2.07% | 138,530 | 122.29M |
| 421 | OMER | Omeros Corporation | 754.15M | -0.76% | 280,981 | 9.89M |
| 422 | CBLL | CeriBell, Inc. | 744.82M | 2.61% | 62,541 | 95.07M |
| 423 | DRUG | Bright Minds Biosciences Inc. | 743.89M | 1.88% | 139,621 | - |
| 424 | IMMX | Immix Biopharma, Inc. | 732.54M | -3.65% | 288,877 | - |
| 425 | GYRE | Gyre Therapeutics, Inc. | 731.37M | 3.47% | 16,801 | 117.05M |
| 426 | SPRY | ARS Pharmaceuticals, Inc. | 728.89M | -3.55% | 687,955 | 98.99M |
| 427 | CADL | Candel Therapeutics, Inc. | 728.31M | 0.71% | 264,148 | - |
| 428 | SSII | SS Innovations International, Inc. | 727.48M | -0.95% | 13,410 | 48.47M |
| 429 | XOMA | XOMA Royalty Corporation | 710.16M | -9.16% | 6,711,917 | 48.56M |
| 430 | CSTL | Castle Biosciences, Inc. | 708.05M | 0.97% | 24,555 | 339.92M |
| 431 | SLBT | SL Science Holding Limited | 703.07M | -0.91% | 27,521 | - |
| 432 | MNPR | Monopar Therapeutics Inc. | 691.65M | 3.47% | 62,812 | - |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 676.50M | -4.25% | 64,312 | - |
| 434 | PHR | Phreesia, Inc. | 673.75M | 1.49% | 116,845 | 495.59M |
| 435 | SGP | SpyGlass Pharma, Inc. | 670.34M | 0.30% | 33,680 | - |
| 436 | EVH | Evolent Health, Inc. | 667.01M | -4.20% | 1,082,691 | 1.89B |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 661.75M | 1.01% | 357,150 | 361.51M |
| 438 | MDXG | MiMedx Group, Inc. | 651.64M | 4.17% | 162,883 | 389.42M |
| 439 | RLMD | Relmada Therapeutics, Inc. | 647.17M | -0.64% | 210,500 | - |
| 440 | TCMD | Tactile Systems Technology, Inc. | 646.69M | 3.80% | 28,520 | 343.52M |
| 441 | CRMD | CorMedix Inc. | 640.17M | -1.33% | 197,671 | 400.05M |
| 442 | ACHV | Achieve Life Sciences, Inc. | 635.46M | -1.90% | 586,115 | - |
| 443 | ALLO | Allogene Therapeutics, Inc. | 635.08M | -0.54% | 1,509,933 | 22.00K |
| 444 | CERS | Cerus Corporation | 628.16M | 2.12% | 204,701 | 216.56M |
| 445 | PRME | Prime Medicine, Inc. | 625.84M | -0.14% | 623,219 | 4.03M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 624.66M | -4.90% | 27,053 | - |
| 447 | RGNX | REGENXBIO Inc. | 614.18M | -3.34% | 301,049 | 87.82M |
| 448 | WEAV | Weave Communications, Inc. | 601.12M | 1.68% | 305,377 | 248.72M |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 599.09M | -2.05% | 109,060 | 88.24M |
| 450 | ANGO | AngioDynamics, Inc. | 598.91M | 11.46% | 523,176 | 320.17M |
| 451 | CTKB | Cytek Biosciences, Inc. | 597.93M | 0.22% | 94,309 | 204.17M |
| 452 | DNA | Ginkgo Bioworks Holdings, Inc. | 597.07M | 1.11% | 143,657 | 151.40M |
| 453 | AGMB | AgomAb Therapeutics NV | 594.92M | 0.33% | 81,932 | - |
| 454 | NVCT | Nuvectis Pharma, Inc. | 590.00M | 2.32% | 33,082 | - |
| 455 | FLGT | Fulgent Genetics, Inc. | 587.04M | 1.03% | 29,245 | 320.35M |
| 456 | MYGN | Myriad Genetics, Inc. | 586.05M | 2.73% | 176,931 | 829.00M |
| 457 | BWAY | BrainsWay Ltd. | 582.31M | 4.57% | 32,887 | 56.22M |
| 458 | TOI | The Oncology Institute, Inc. | 579.40M | -7.72% | 776,682 | 545.76M |
| 459 | ALT | Altimmune, Inc. | 575.64M | 1.02% | 848,858 | 36.00K |
| 460 | NPCE | NeuroPace, Inc. | 557.43M | 3.22% | 19,919 | 99.53M |
| 461 | EIKN | Eikon Therapeutics, Inc. | 541.39M | -1.86% | 36,706 | - |
| 462 | TLRY | Tilray Brands, Inc. | 534.98M | 2.40% | 1,476,790 | 858.28M |
| 463 | ARVN | Arvinas, Inc. | 531.01M | -0.48% | 133,289 | 89.40M |
| 464 | ASMB | Assembly Biosciences, Inc. | 528.03M | -0.43% | 21,403 | 71.10M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 527.52M | -3.16% | 35,250 | - |
| 466 | KIDS | OrthoPediatrics Corp. | 508.82M | 2.91% | 32,587 | 243.30M |
| 467 | CTEV | Claritev Corporation | 504.44M | 4.34% | 28,116 | 978.76M |
| 468 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 469 | CBIO | Crescent Biopharma, Inc. | 503.75M | -0.95% | 996,883 | 11.88M |
| 470 | NRC | NRC Health | 502.46M | 1.43% | 8,133 | 138.64M |
| 471 | RZLT | Rezolute, Inc. | 492.56M | -2.38% | 202,444 | - |
| 472 | AQST | Aquestive Therapeutics, Inc. | 492.46M | -2.85% | 651,406 | 50.27M |
| 473 | STTK | Shattuck Labs, Inc. | 491.52M | 1.91% | 344,364 | 1.00M |
| 474 | ZURA | Zura Bio Limited | 491.14M | 2.17% | 176,018 | - |
| 475 | OCGN | Ocugen, Inc. | 490.86M | 1.40% | 1,094,685 | 4.47M |
| 476 | SOPH | SOPHiA GENETICS SA | 484.08M | 1.58% | 51,534 | 81.18M |
| 477 | PROK | ProKidney Corp. | 483.30M | 3.23% | 269,674 | 889.00K |
| 478 | VSTM | Verastem, Inc. | 481.55M | -1.62% | 460,273 | 49.59M |
| 479 | EDIT | Editas Medicine, Inc. | 480.34M | -0.95% | 288,427 | 38.69M |
| 480 | VALN | Valneva SE | 478.73M | 0.39% | 16,313 | 180.25M |
| 481 | CLPT | ClearPoint Neuro, Inc. | 477.13M | -0.31% | 96,953 | 40.61M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 474.81M | -1.64% | 501,629 | - |
| 483 | SGMT | Sagimet Biosciences Inc. | 473.02M | -1.23% | 268,976 | - |
| 484 | PACB | Pacific Biosciences of California, Inc. | 470.56M | 1.00% | 1,095,806 | 160.03M |
| 485 | SRTA | Strata Critical Medical, Inc. | 468.54M | 2.56% | 200,630 | 228.58M |
| 486 | SLN | Silence Therapeutics plc | 467.14M | 1.44% | 194,880 | 839.00K |
| 487 | OVID | Ovid Therapeutics Inc. | 464.73M | 1.22% | 360,847 | 7.12M |
| 488 | VMD | Viemed Healthcare, Inc. | 461.00M | 0.71% | 74,034 | 286.57M |
| 489 | ARTV | Artiva Biotherapeutics, Inc. | 458.67M | 0.96% | 170,968 | 251.00K |
| 490 | SI | Shoulder Innovations, Inc. | 454.37M | 1.48% | 12,383 | 53.89M |
| 491 | OFIX | Orthofix Medical Inc. | 453.53M | 2.47% | 40,673 | 825.37M |
| 492 | VREX | Varex Imaging Corporation | 451.39M | 1.32% | 57,352 | 857.50M |
| 493 | CABA | Cabaletta Bio, Inc. | 448.40M | 3.00% | 830,935 | - |
| 494 | PRTA | Prothena Corporation plc | 446.57M | -1.27% | 56,644 | 57.94M |
| 495 | DCTH | Delcath Systems, Inc. | 445.85M | -1.71% | 53,929 | 90.44M |
| 496 | BNTC | Benitec Biopharma Inc. | 443.34M | -0.58% | 4,012 | - |
| 497 | CYH | Community Health Systems, Inc. | 442.93M | 2.51% | 653,275 | 12.29B |
| 498 | PRLD | Prelude Therapeutics Incorporated | 437.37M | 0.46% | 62,030 | 16.72M |
| 499 | EVMN | Evommune, Inc. | 431.32M | -0.13% | 167,730 | 10.00M |
| 500 | STRO | Sutro Biopharma, Inc. | 427.64M | -0.85% | 54,698 | 99.61M |